摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl methacrylate

中文名称
——
中文别名
——
英文名称
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl methacrylate
英文别名
Cholesteryl methacrylate;[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-methylprop-2-enoate
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl methacrylate化学式
CAS
——
化学式
C31H50O2
mdl
——
分子量
454.737
InChiKey
ZHNSYNYLKYUVAH-GTPODGLVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.1
  • 重原子数:
    33
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.84
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Novel Trifunctional Building Blocks for Fluorescent Polymers
    摘要:
    [GRAPHICS]Herein, we describe the synthesis of fluorescent 2-(arylsulfonyl)methacrylates and its polymers. These novel trifunctional monomers, possessing a fluorescent arylsulfonyl (ArSO2) group, an alkyl group (R), and a polymerizable olefin, serve as useful building blocks for functionalized fluorescent polymers.
    DOI:
    10.1021/ol035500m
  • 作为产物:
    参考文献:
    名称:
    通过调整主链结构和灵活的间隔基长度来自组织胆固醇侧链液晶聚合物
    摘要:
    三种侧链液晶聚合物(SCLCP),其中胆甾醇型液晶元(Chol)与聚丙烯酸酯(PCholAC- m),聚甲基丙烯酸酯(PCholMC- m)和聚(2-乙烯基苯-1,4-二酸酯)连接通过自由基聚合成功地合成了通过不同长度(m = 0、2、4、6、8和10)的亚甲基间隔基形成的(PCholVA- m)主链。使用DSC,POM和SAXS详细研究了聚合物的相行为和结构。结果表明,通过改变主链结构和间隔区长度,Chol-SCLCPs表现出有趣的自组织。所述聚合物最初形成近晶A相,除了没有液晶相的PCholAC-0以外。接下来,聚合物PCholAC-m(m= 2、4、6)形成两层近晶A相,其中烷基尾部重叠(SmA 2)。在PCholAC- m(m = 8,10)中观察到两相共存结构,包括双层近晶A相(其中烷基尾部插入到液晶元中)(SmA d)和单层近晶A相,其中液晶元重叠(SmA 1)。对于PCholMC-
    DOI:
    10.1039/c8nj06168h
点击查看最新优质反应信息

文献信息

  • Cosmetic or dermatological preparations based on emulsifiers which are free from ethylene oxide and propylene oxide, for the preparation of microemulsion gels
    申请人:Beiersdorf AG
    公开号:US06468551B1
    公开(公告)日:2002-10-22
    Microemulsion gels a) based on oil in water type, comprising an oil phase, substantially consisting of not easily volatile constituents, and an aqueous phase containing one or more O/W emulsifiers free from ethylene oxide and propylene oxide and possibly one or more additional O/W emulsifiers, an emulsifier content which is lower than 20 wt. % related to the full weight of the microemulsion, obtained in such a way that a mixture of basic constituents, consisting of an aqueous phase, an oil phase, one or more O/W emulsifiers, possibly one or more additional O/W emulsifiers, possibly other auxiliary, additional or active agents, is made to react against each other in a mixing ratio so that a microemulsion can be obtained and b) in which droplets of discontinuous oil phase are bound to each other by one or more cross-linking substances, whose molecules are characterized by at least one hydrophylic area having a suitable expansion for bridging of distance between each microemulsion droplet and at least one hydropobic area, which can interact hydrophobically with the microemulsion droplets.
    微乳凝胶a)基于中油型,包括油相,主要由不易挥发的成分组成,以及含有一个或多个不含乙氧基和丙烯氧基的O/W乳化剂相,可能还含有一个或多个额外的O/W乳化剂乳化剂含量低于微乳凝胶的总重量的20重量%,通过使基本成分的混合物相互反应而获得,该混合物包括相,油相,一个或多个O/W乳化剂,可能还有一个或多个额外的O/W乳化剂,可能还有其他辅助、额外或活性剂,混合比例使微乳凝胶可以获得;b)其中不连续的油相的液滴通过一个或多个交联物质相互结合,这些分子至少具有一个适合于在每个微乳凝胶液滴之间桥接距离的亲区域和至少一个疏区域,可以与微乳凝胶液滴发生疏相互作用。
  • [EN] NUCLEIC ACID COMPLEX<br/>[FR] COMPLEXE D'ACIDE NUCLÉIQUE
    申请人:COMMW SCIENT IND RES ORG
    公开号:WO2013003887A1
    公开(公告)日:2013-01-10
    The present invention relates to a complex comprising a cationic block copolymer and a nucleic acid, the cationic block copolymer having at least a tri-block structure comprising a cationic block and two hydrophilic blocks, or a hydrophilic block and two cationic blocks.
    本发明涉及一种包含阳离子嵌段共聚物和核酸的复合物,其中所述阳离子嵌段共聚物至少具有三嵌段结构,包括一个阳离子嵌段和两个亲性嵌段,或一个亲性嵌段和两个阳离子嵌段。
  • [EN] BRANCHED PEG MOLECULES AND RELATED COMPOSITIONS AND METHODS<br/>[FR] MOLÉCULES DE PEG RAMIFIÉ, COMPOSITIONS ET PROCÉDÉS ASSOCIÉS
    申请人:PHASERX INC
    公开号:WO2018126084A1
    公开(公告)日:2018-07-05
    Disclosed are branched PEG molecules, including branched PEG-lipids and branched-PEG proteins, as well as related compositions and methods for making branched PEG molecules. Also disclosed are related compositions, systems, and methods for in vivo delivery of therapeutic and diagnostic agents.
    揭示了分支聚乙二醇(PEG)分子,包括分支PEG-脂质和分支PEG-蛋白质,以及制备分支PEG分子的相关组合物和方法。还公开了相关的组合物、系统和方法,用于体内传递治疗和诊断试剂。
  • [EN] THIOCARBONYLTHIO COMPOUNDS AS CHAIN TRANSFER AGENTS SUITABLE FOR RAFT POLYMERIZATION<br/>[FR] COMPOSÉS THIOCARBONYLTHIO EN TANT QU'AGENTS DE TRANSFERT DE CHAÎNE ADAPTÉS POUR LA POLYMÉRISATION EN RADEAU
    申请人:UNIV IOWA STATE RES FOUND INC
    公开号:WO2018009830A1
    公开(公告)日:2018-01-11
    The present invention relates to a compound having the structure of formula (I), wherein R1, R2, R3, R4, R5, R6, and R7 are as described herein. The present invention also relates to a process for the preparation of a compound of formula (I) and to a process for the synthesis of a polymer using the compound of formula (I) through controlled free radical polymerization.
    本发明涉及一种具有如下结构的化合物,其中R1、R2、R3、R4、R5、R6和R7如本文所述。本发明还涉及一种制备式(I)化合物的方法,以及一种利用式(I)化合物通过受控自由基聚合合成聚合物的方法。
  • MIKTO-ARM BRANCHED POLYMERS
    申请人:COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
    公开号:US20160375143A1
    公开(公告)日:2016-12-29
    The invention relates to branched polymer comprising a support moiety and at least three homopolymer chains each covalently coupled to and extending from the support moiety, wherein the at least three homopolymer chains include a cationic homopolymer chain, a hydrophilic homopolymer chain, and a hydrophobic homopolymer chain.
    本发明涉及一种分支聚合物,包括支撑基团和至少三条同源聚合物链,每条聚合物链都与支撑基团共价耦合并延伸出来,其中至少三条同源聚合物链包括阳离子聚合物链、亲性聚合物链和疏性聚合物链。
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B